Rosati Robert L.
No ORCID on file
· 39 papers in corpus
· active 2000-2004
Frequent coauthors
2004
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2004
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2004
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2004
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2004
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2004
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2004
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2004
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2004
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2004
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2004
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2004
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2004
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2001
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2001
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2001
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2001
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2001
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2001
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2001
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2001
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2001
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2001
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2001
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.
2001
Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.